|
Synonyms: ATN161 | N-acetyl-L-prolyl-L-histidyl-L-seryl-L-cysteinyl-L-asparaginamide
Compound class:
Peptide
Comment: ATN-161 is a penta-peptide integrin α5β1 antagonist [5]. It interferes with the interaction between the integrin on endothelial cells and fibronection in the extracellular matrix (ECM) [3]. ATN-161 was primarily proposed as an anti-tumour agent with potential to disrupt neoangiogenesis [1,5,7]. It has subsequently been explored for antimicrobial/anti-infection potential [2,4,6,9].
Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
|||||||||||||||||
| References |
|
1. Cianfrocca ME, Kimmel KA, Gallo J, Cardoso T, Brown MM, Hudes G, Lewis N, Weiner L, Lam GN, Brown SC et al.. (2006)
Phase 1 trial of the antiangiogenic peptide ATN-161 (Ac-PHSCN-NH(2)), a beta integrin antagonist, in patients with solid tumours. Br J Cancer, 94 (11): 1621-6. [PMID:16705310] |
|
2. Gracie NP, Aggarwal A, Luo R, Spicer M, Idrees S, Ashley CL, Alca S, Ison T, Steain MC, Patel K et al.. (2025)
An RGD motif on SARS-CoV-2 Spike induces TGF-β signaling and downregulates interferon. J Virol, 99 (9): e0043525. [PMID:40905682] |
|
3. Khalili P, Arakelian A, Chen G, Plunkett ML, Beck I, Parry GC, Doñate F, Shaw DE, Mazar AP, Rabbani SA. (2006)
A non-RGD-based integrin binding peptide (ATN-161) blocks breast cancer growth and metastasis in vivo. Mol Cancer Ther, 5 (9): 2271-80. [PMID:16985061] |
|
4. Liu X, Yuan Z, Wan Z, Yuan X, Wang Y, Gao Y, Zhang L, Song R, Sang J, Wang Y et al.. (2026)
P. gingivalis-host interactions direct antibiotic adjuvants for periodontitis antimicrobial therapy. Int J Oral Sci, 18 (1). [PMID:42425934] |
|
5. Livant DL, Brabec RK, Pienta KJ, Allen DL, Kurachi K, Markwart S, Upadhyaya A. (2000)
Anti-invasive, antitumorigenic, and antimetastatic activities of the PHSCN sequence in prostate carcinoma. Cancer Res, 60 (2): 309-20. [PMID:10667582] |
|
6. Silva RS, Souza LMP, Costa RKM, Souza FR, Pimentel AS. (2023)
Absolute binding free energies of the antiviral peptide ATN-161 with protein targets of SARS-CoV-2. J Biomol Struct Dyn, 41 (20): 10546-10557. [PMID:36476274] |
|
7. Stoeltzing O, Liu W, Reinmuth N, Fan F, Parry GC, Parikh AA, McCarty MF, Bucana CD, Mazar AP, Ellis LM. (2003)
Inhibition of integrin alpha5beta1 function with a small peptide (ATN-161) plus continuous 5-FU infusion reduces colorectal liver metastases and improves survival in mice. Int J Cancer, 104 (4): 496-503. [PMID:12584749] |
|
8. White ES, Livant DL, Markwart S, Arenberg DA. (2001)
Monocyte-fibronectin interactions, via alpha(5)beta(1) integrin, induce expression of CXC chemokine-dependent angiogenic activity. J Immunol, 167 (9): 5362-6. [PMID:11673553] |
|
9. Zhang H, Wang Z, Nguyen HTT, Watson AJ, Lao Q, Li A, Zhu J. (2023)
Integrin α5β1 contributes to cell fusion and inflammation mediated by SARS-CoV-2 spike via RGD-independent interaction. Proc Natl Acad Sci U S A, 120 (50): e2311913120. [PMID:38060559] |